Literature DB >> 19589781

Nuclear export-independent inhibition of Foxa2 by insulin.

Jessica J Howell1, Markus Stoffel.   

Abstract

The Forkhead box A2 transcription factor (Foxa2/HNF-3beta) has been shown to be a key regulator of genes involved in the maintenance of glucose and lipid homeostasis in the liver. It is constitutively inactivated in several hyperinsulinemic/obese mouse models, thereby enhancing their metabolic phenotypes. Foxa2 is activated under fasting conditions but is inhibited by insulin signaling via phosphatidylinositol 3-kinase/AKT in a phosphorylation-dependent manner, which results in its nuclear exclusion. However, the mechanism and relative importance of its nuclear export has not yet been elucidated. Here we show that Foxa2 contains a functional nuclear export signal and is excluded from the nucleus via a CRM1-dependent pathway in response to insulin signaling. Furthermore, direct evidence is provided that nuclear export-defective Foxa2 is phosphorylated and inactivated by insulin in vitro and in vivo. These data demonstrate for the first time that phosphorylation itself is the main event regulating the activity of Foxa2, suggesting that export-independent mechanisms have evolved to ensure inhibition of Foxa2 under conditions in which insulin signaling is present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589781      PMCID: PMC2757185          DOI: 10.1074/jbc.M109.042135

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

Authors:  Christian Wolfrum; Esra Asilmaz; Edlira Luca; Jeffrey M Friedman; Markus Stoffel
Journal:  Nature       Date:  2004-12-23       Impact factor: 49.962

Review 2.  Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.

Authors:  Peter K Vogt; Hao Jiang; Masahiro Aoki
Journal:  Cell Cycle       Date:  2005-07-03       Impact factor: 4.534

3.  A methionine-rich domain mediates CRM1-dependent nuclear export activity of Borna disease virus phosphoprotein.

Authors:  Hideyuki Yanai; Takeshi Kobayashi; Yohei Hayashi; Yohei Watanabe; Naohiro Ohtaki; Guoqi Zhang; Juan Carlos de la Torre; Kazuyoshi Ikuta; Keizo Tomonaga
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion.

Authors:  Christian Wolfrum; Markus Stoffel
Journal:  Cell Metab       Date:  2006-02       Impact factor: 27.287

5.  Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence.

Authors:  J E Ayala; R S Streeper; J S Desgrosellier; S K Durham; A Suwanichkul; C A Svitek; J K Goldman; F G Barr; D R Powell; R M O'Brien
Journal:  Diabetes       Date:  1999-09       Impact factor: 9.461

6.  Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice.

Authors:  D Q Shih; M A Navas; S Kuwajima; S A Duncan; M Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Foxa2 activity increases plasma high density lipoprotein levels by regulating apolipoprotein M.

Authors:  Christian Wolfrum; Jessica J Howell; Esther Ndungo; Markus Stoffel
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

8.  Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.

Authors:  Hannes Oberkofler; Michael Hafner; Thomas Felder; Franz Krempler; Wolfgang Patsch
Journal:  J Mol Med (Berl)       Date:  2008-12-11       Impact factor: 4.599

9.  Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Toyonori Kato; Ayaka Atsumi; Takashi Yamamoto; Noriyuki Inoue; Mayumi Ishikawa; Sumiyo Okada; Naomi Ishigaki; Hitoshi Iwasaki; Yuko Iwasaki; Tadayoshi Karasawa; Shin Kumadaki; Toshiyuki Matsui; Motohiro Sekiya; Ken Ohashi; Alyssa H Hasty; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Sigeru Yatoh; Hirohito Sone; Hideo Toyoshima; Jun-ichi Osuga; Nobuhiro Yamada
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

Review 10.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

View more
  15 in total

1.  Forkhead box A1 (FOXA1) is a key mediator of insulin-like growth factor I (IGF-I) activity.

Authors:  Adam S Potter; Angelo J Casa; Adrian V Lee
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

2.  Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.

Authors:  Kazuaki Ohtsubo; Mark Z Chen; Jerrold M Olefsky; Jamey D Marth
Journal:  Nat Med       Date:  2011-08-14       Impact factor: 53.440

3.  Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling.

Authors:  Sarah Kohler; Lisa Ann Cirillo
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

4.  Pregnane X Receptor Represses HNF4α Gene to Induce Insulin-Like Growth Factor-Binding Protein IGFBP1 that Alters Morphology of and Migrates HepG2 Cells.

Authors:  Susumu Kodama; Yuichi Yamazaki; Masahiko Negishi
Journal:  Mol Pharmacol       Date:  2015-07-31       Impact factor: 4.436

5.  Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors.

Authors:  Barbara R Tschida; Nuri A Temiz; Timothy P Kuka; Lindsey A Lee; Jesse D Riordan; Carlos A Tierrablanca; Robert Hullsiek; Sandra Wagner; Wendy A Hudson; Michael A Linden; Khalid Amin; Pauline J Beckmann; Rachel A Heuer; Aaron L Sarver; Ju Dong Yang; Lewis R Roberts; Joseph H Nadeau; Adam J Dupuy; Vincent W Keng; David A Largaespada
Journal:  Cancer Res       Date:  2017-10-09       Impact factor: 12.701

6.  Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver.

Authors:  Marta Moya; Marta Benet; Carla Guzmán; Laia Tolosa; Carmelo García-Monzón; Eugenia Pareja; José Vicente Castell; Ramiro Jover
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

7.  Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data.

Authors:  Natalie L Catlett; Anthony J Bargnesi; Stephen Ungerer; Toby Seagaran; William Ladd; Keith O Elliston; Dexter Pratt
Journal:  BMC Bioinformatics       Date:  2013-11-23       Impact factor: 3.169

Review 8.  Structural Basis of Targeting the Exportin CRM1 in Cancer.

Authors:  Achim Dickmanns; Thomas Monecke; Ralf Ficner
Journal:  Cells       Date:  2015-09-21       Impact factor: 6.600

Review 9.  Role of transcription factor acetylation in the regulation of metabolic homeostasis.

Authors:  Joo-Man Park; Seong-Ho Jo; Mi-Young Kim; Tae-Hyun Kim; Yong-Ho Ahn
Journal:  Protein Cell       Date:  2015-09-03       Impact factor: 14.870

10.  SIRT1 mediates FOXA2 breakdown by deacetylation in a nutrient-dependent manner.

Authors:  Rogier van Gent; Claudio Di Sanza; Niels J F van den Broek; Veerle Fleskens; Aukje Veenstra; Gerdine J Stout; Arjan B Brenkman
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.